Gemfibrozil and Hypercalcaemia aggravated - a phase IV clinical study of FDA data

Summary:

Hypercalcaemia aggravated is reported as a side effect among people who take Gemfibrozil (gemfibrozil), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Nexium, and have Metastases to bone.

The phase IV clinical study analyzes which people have Hypercalcaemia aggravated when taking Gemfibrozil. It is created by eHealthMe based on reports of 17,763 people who have side effects when taking Gemfibrozil from the FDA, and is updated regularly.

What is Gemfibrozil?

Gemfibrozil has active ingredients of gemfibrozil. It is often used in high blood cholesterol. eHealthMe is studying from 18,213 Gemfibrozil users. Check the latest studies of Gemfibrozil.

What is Hypercalcaemia aggravated?

Hypercalcaemia aggravated (elevated calcium (ca+) level in the blood. (norma) is found to be associated with 933 drugs and 343 conditions by eHealthMe. Check the latest studies of Hypercalcaemia aggravated.

On Jul, 07, 2026

17,763 people reported to have side effects when taking Gemfibrozil.
Among them, 20 people (0.11%) have Hypercalcaemia aggravated.

Could Gemfibrozil cause Hypercalcaemia aggravated?

Among these 20 people:

How long have people been on Gemfibrozil when they have Hypercalcaemia aggravated? *

What is the gender of people who have Hypercalcaemia aggravated when taking Gemfibrozil? *

female: 65 %
male: 35 %

What is the age of people who have Hypercalcaemia aggravated when taking Gemfibrozil? *

What are other drugs people take besides Gemfibrozil? *

What are other side effects people have besides Hypercalcaemia aggravated? *

Acute Kidney Failure: 11 people, 55.00%
Hyperkalemia (damage to or disease of the kidney): 10 people, 50.00%
Pneumonia: 10 people, 50.00%
Back Pain: 10 people, 50.00%
Pain: 10 people, 50.00%
Weight Loss: 9 people, 45.00%
Gastritis (inflammation of stomach): 9 people, 45.00%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 9 people, 45.00%
Insomnia (sleeplessness): 9 people, 45.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 9 people, 45.00%

What are the existing conditions these people have? *

Metastases To Bone (cancer spreads to bone): 7 people, 35.00%
High Blood Pressure: 4 people, 20.00%
Osteoporosis (bones weak and more likely to break): 3 people, 15.00%
Urinary Tract Infection: 2 people, 10.00%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 10.00%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 2 people, 10.00%
Device Related Infection: 2 people, 10.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 10.00%
Glaucoma (increased fluid pressure in the eye with vision loss): 2 people, 10.00%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 2 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Gemfibrozil and have Hypercalcaemia aggravated?

- Check whether Hypercalcaemia aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gemfibrozil:

Gemfibrozil (18,213 reports)

Browse all side effects of Gemfibrozil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypercalcaemia aggravated:

Hypercalcaemia aggravated (933 drugs)

Browse all the conditions that are associated with Hypercalcaemia aggravated:

Hypercalcaemia aggravated (343 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on gemfibrozil (the active ingredients of Gemfibrozil) and Gemfibrozil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.